Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORPHENADRINE vs OSPEMIFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORPHENADRINE vs OSPEMIFENE: Safety Overview

Metric ORPHENADRINE OSPEMIFENE
Total FAERS Reports 584 2,047
Deaths Reported 121 2
Death Rate 20.7% 0.1%
Hospitalizations 159 60
Average Patient Age 47.9 yrs 61.7 yrs
% Female Patients 79.3% 99.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Feb 13, 2024
Manufacturer Sandoz Inc Duchesnay USA, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription